Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

A Roadmap to Immunotherapy: Lesson from the Hallmarks and Signaling Pathways of Cancer

Version 1 : Received: 1 November 2020 / Approved: 2 November 2020 / Online: 2 November 2020 (11:28:51 CET)

How to cite: Derakhshani, A.; Rostami, Z.; Safarpour, H.; Taefehshokr, S.; Tabrizi, N.J.; Abdoli Shadbad, M.; Kooshkaki, O.; Astamal, R.V.; Argentiero, A.; Singh, P.K.; Taefehshokr, N.; Alizadeh, N.; Silvestris, N.; Baradaran, B. A Roadmap to Immunotherapy: Lesson from the Hallmarks and Signaling Pathways of Cancer. Preprints 2020, 2020110034 (doi: 10.20944/preprints202011.0034.v1). Derakhshani, A.; Rostami, Z.; Safarpour, H.; Taefehshokr, S.; Tabrizi, N.J.; Abdoli Shadbad, M.; Kooshkaki, O.; Astamal, R.V.; Argentiero, A.; Singh, P.K.; Taefehshokr, N.; Alizadeh, N.; Silvestris, N.; Baradaran, B. A Roadmap to Immunotherapy: Lesson from the Hallmarks and Signaling Pathways of Cancer. Preprints 2020, 2020110034 (doi: 10.20944/preprints202011.0034.v1).

Abstract

Cancer is the second leading cause of death worldwide. It is theorized that underlying genetic and epigenetic changes enable cells to proliferate out of control by escaping regulatory mechanisms. Although traditional molecular profiling techniques, i.e., bulk sequencing, can identify common mutations and gene expression patterns in cancer cells, they cannot detect tumour heterogeneity. However, single-cell technology has provided an ample opportunity to overcome this difficulty. Since this technology allows us to detect the heterogeneous properties of all cancer cells, this can further our knowledge of the signaling pathways in cancer cells. Indeed, single-cell transcriptomics technology has paved the road for identifying novel biomarkers and signaling pathways, which can serve as targets. This study aims to review the current knowledge about pathways involved in developing cancer cells and shed light on single-cell studies as promising therapeutic approaches.

Subject Areas

cell signaling; signaling pathways; single-cell sequencing; immunotherapy; hallmarks cancer; cancer

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.